Skip to main content
. 2022 Jun 16;13:901979. doi: 10.3389/fmicb.2022.901979

FIGURE 3.

FIGURE 3

Evaluation of the therapeutic effect of γ3-RBCNPs in vitro. (A) Quantification of the number of bacteria in HUVECs treated with NP-cores, RBCNPs, and γ3-RBCNPs after K.P infection. ***P < 0.001 vs. PBS group. Flow cytometry (B) and IF staining (C) detect the apoptosis of HUVECs treated with γ3-RBCNP after K.P infection. Scale bar = 50 μm. ***P < 0.001 vs. unstimulated groups. ###P < 0.001 vs. K.P stimulated PBS group.